Diagnosis, Screening, and Early Detection of Vulvar Cancer
Diagnosing vulvar cancer starts with recognizing a persistent change and ends with a biopsy, since imaging and physical exams alone cannot confirm cancer. This article explains what prompts an evaluation, how vulvar cancer is diagnosed, and why there is no dedicated population-wide screening test for it.
Key Takeaways
- Persistent itching, an unusual lump, or a sore that will not heal are the symptoms most often reported before a vulvar cancer diagnosis, and any of them deserves a prompt medical evaluation.
- A biopsy — removing a small tissue sample for a pathologist to examine under a microscope — is the only way to confirm vulvar cancer; a physical exam, colposcopy, and imaging support the process but cannot replace it.
- There is no dedicated, population-wide screening test for vulvar cancer, unlike the Pap test for cervical cancer; the vulva is checked visually as part of a routine pelvic exam, which is why regular gynecological visits matter.
- Two separate paths raise vulvar cancer risk: a past high-risk HPV infection, and long-standing vulvar skin disease such as lichen sclerosus, which is why people with either history sometimes need closer monitoring.
Recognizing Early Signs of Vulvar Cancer
Recognizing the early signs of vulvar cancer is an important first step toward timely treatment, but the disease does not always announce itself clearly. In its earliest stages, vulvar cancer frequently produces nothing a person would notice, and once symptoms show up, they often look like ordinary skin irritation or a benign genital condition rather than cancer. It is the persistence of a change — not any single symptom on its own — that should prompt a visit to a clinician rather than waiting to see if it resolves.
Signs and symptoms that are worth checking with a doctor include:
- Itching in the vulvar area that persists despite typical treatment
- A new lump, growth, or sore with a wart-like or ulcer-like appearance
- Bleeding unrelated to a menstrual cycle
- Pain or tenderness in the vulvar area
Because these changes can also be caused by infections or dermatological conditions, many people delay seeking care. Any of them lasting or worsening rather than clearing up is the cue to have it looked at, even if it initially seemed minor.
Vulvar Cancer Diagnosis Methods
When a possible sign of vulvar cancer is present, the workup usually opens with a conversation about symptoms and health background, paired with a physical exam, before moving toward more targeted tests that determine whether an area is cancer and, if so, which type.
Part of this evaluation is a pelvic exam, which lets the clinician inspect the vulva, vagina, and cervix directly; a Pap test or HPV test may be done at the same visit. If an area looks suspicious, the clinician may use a colposcope — a lighted, magnifying instrument — to examine it more closely and guide where a biopsy sample is taken. Colposcopy is a tool for a closer look at a lesion that has already been noticed on exam, not a stand-alone test used on its own.
If cancer is confirmed, scans such as an MRI, a CT, or a combined PET-CT are sometimes added afterward — their role is mapping whether the disease reaches nearby lymph nodes or other tissue, not making the initial diagnosis.
Physical Examination and History
The diagnostic process usually begins with a conversation about symptoms, how long they have lasted, and any relevant risk factors, followed by a careful exam. During the pelvic exam, the clinician visually inspects the vulva, vagina, and cervix and also checks the groin area, since whether cancer has reached the nearby (inguinal) lymph nodes is an important factor clinicians look at when evaluating vulvar cancer. This initial assessment helps identify which areas need a closer look or a biopsy.
Biopsy and Pathology
A biopsy is the only way to confirm a vulvar cancer diagnosis. A small sample of the abnormal tissue is removed and sent to a lab, where a pathologist studies it under the microscope, looking for cancer cells and, if present, the exact cell type; depending on the size and location of the area, the procedure may be done under anesthesia. According to the National Cancer Institute, more than 9 in 10 vulvar cancers identified this way turn out to be squamous cell carcinoma, though the pathology report can also identify rarer types. This pathology result guides staging and treatment planning.
| Diagnostic Step | What It Involves | What It Shows |
|---|---|---|
| Physical exam & pelvic exam | Visual inspection and pelvic exam of the vulva, vagina, and cervix; the groin area is also checked. | Identifies suspicious areas and possible lymph node involvement. |
| Colposcopy | Magnified inspection of a suspicious area with a colposcope. | Guides where a biopsy sample is taken. |
| Biopsy | Removal of a tissue sample for microscopic examination by a pathologist. | Confirms cancer and identifies the cell type, most often squamous cell carcinoma. |
| Imaging (MRI, CT, PET-CT) | Scans performed once cancer is confirmed. | Extent of disease and possible spread to lymph nodes or other tissue. |
Vulvar Cancer Screening and Early Detection
Unlike cervical cancer, which has a well-established Pap test screening program, there is no dedicated, population-wide screening test for vulvar cancer. This is not an oversight in care: the disease is uncommon enough, relative to other gynecologic cancers, that a mass screening program is not considered a practical population-level strategy.
That does not mean there is no chance for early detection. A visual check of the vulva is part of a standard pelvic exam, so regular gynecological visits — even when nothing feels wrong — give a clinician the opportunity to notice a change before it becomes symptomatic. People with a higher-than-average risk, including those with a history of high-risk HPV infection, vulvar intraepithelial neoplasia (VIN), or a chronic vulvar skin condition such as lichen sclerosus, may be advised to have closer follow-up, since these conditions can each lead to vulvar cancer through a different pathway.
Because no formal screening test exists, awareness remains the most effective early-detection tool: bringing a new lump, ongoing itching, unusual bleeding, or a non-healing sore to a clinician promptly instead of watching and waiting for it to clear up unassisted.
Frequently Asked Questions
What are the most common symptoms of vulvar cancer?
The most frequently reported signs are itching that will not settle down and a new lump, growth, or open sore with a wart-like or ulcerated look. Bleeding outside of a normal period and vulvar pain or tenderness can also occur. Because vulvar cancer sometimes causes no early symptoms at all, any of these changes — even a mild one that persists — is worth mentioning to a doctor.
Is there a routine screening test for vulvar cancer?
No. Unlike the Pap test used for cervical cancer, there is no dedicated, population-wide vulvar cancer screening test. The vulva is examined visually as part of a routine pelvic exam, so regular gynecological check-ups remain the main opportunity for a clinician to notice a change, particularly for people with risk factors such as HPV infection or vulvar intraepithelial neoplasia.
How is vulvar cancer definitively diagnosed?
A biopsy is required for a definitive diagnosis. When a physical exam or colposcopy points to a suspicious area, a small tissue sample is taken from it, and a pathologist reviews the sample under the microscope to confirm whether cancer cells are present and, if so, which type. Imaging may follow to see whether the disease has spread.
Sources
